[1]
2012. Impact of dendrine-cell autovaccine on the efficacy of primary treatment for patients with ovarian cancer. Voprosy onkologii. 58, 6 (Dec. 2012), 781–786. DOI:https://doi.org/10.37469/0507-3758-2012-58-6-781-786.